Methods Mentioned
BETA
Assay
chip
Software Mentioned
GraphPad Prisim
AutoDock Tools
Discovery Studio
Studio
AutoDock Vina 33
Discovery
AutoDock Vina
SpectraMax
AutoDock
Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Journal of Medicinal Chemistry
Deheng SunHonglin Li
European Journal of Medicinal Chemistry
Jee Sun YangGyoonhee Han
British Journal of Cancer
W-H LinJohn T-A Hsu
European Journal of Medicinal Chemistry
Hyuntae KimGyoonhee Han
Journal of Medicinal Chemistry
Robert J DaviesMark Namchuk